TBPH 8-K 2026-09-23

Theravance Biopharma, Inc. (TBPH) 8-K dated 2026-09-23 — accession 0001104659-26-109979. This URL is the filing, not the TBPH hub.

Theravance Biopharma, Inc. (TBPH) is a biotechnology company listed on NASDAQ.

Theravance Biopharma, Inc. filed a 8-K on 2026-09-23. Accession 0001104659-26-109979.

Cached items: 1.01, 2.01, 3.01, 3.03, 5.01, 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TBPH revenue for 2026-06-30 was $20.7M. Net income was -$5.9M. Revenue was up 17.1% from 2026-03-31 to 2026-06-30. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.

Not investment advice. The TBPH SEC hub lists recent forms. The stock page is the research view.